 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | United Nations Development Programme |
| Street 1: | 11-13 Chemin des Anémones |
| Street 2: | Châtelaine |
| City: | Geneva |
| Province: | |
| Post Code: | CH -1219 |
| Country: | Switzerland |
| Phone: | +41 22 917 8288 |
| Email: | saleban.omar@undp.org |
| Web Site: | http://www.undp.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Organization Type - Primary: | Multilateral Organization |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| UNDP is the United Nations' global development network, an organization advocating for change and connecting countries to knowledge, experience and resources to help people build a better life. We are on the ground in 177 countries, working with them on their own solutions to global and national development challenges. Our focus is helping countries build and share solutions to the challenges of Democratic Governance, Poverty Reduction, Crisis Prevention & Recovery, Environment & Energy and HIV/AIDS. UNDP is working with a broad range of partners to help create coalitions for change to support achievement of the Millennium Development Goals,at global, regional and national levels, to benchmark progress towards them, and to help countries to build the institutional capacity, policies and programmes to achieve the MDGs, including the MDG to promote the goal to combat HIV/AIDS, malaria and other diseases including tuberculosis. Within the context of UNDP's partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria, UNDP is directly supporting implementation of TB grants as the Principal Recipient of Last Resort in a number of countries across all regions. In addition UNDP is working on addressing social determinants of health, including TB. TB has often been described as a disease of poverty. Despite the enormous success of DOTS in treating and caring for those infected with TB, DOTS on its own is unlikely to achieve sustained, effective TB control globally. Combination approaches that simultaneously address the social and the biomedical dimensions of TB are urgently needed. In collaboration with a variety of partners, including WHO’s StopTB programme, UNDP is exploring such combination approaches, leveraging its experience in supporting action on the social determinants of HIV. Specifically, UNDP is exploring the ways in which emerging work in HIV-sensitive social protection might be translated to address the underlying socio-economic drivers of TB. UNDP is also working to promo |
|
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 51 - 99 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | >$10 MIL |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: | Other (please explain) |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Within the context of UNDP's partnership with the Global Fund to Fight AIDS, Tuberculosis and Malaria, UNDP is directly supporting implementation of TB grants as the Principal Recipient of Last Resort in a number of countries across all regions. UNDP is currently Principal Recipient of Last Resort for Global Fund grants in 30 different countries covering implementation of all three diseases. In addition UNDP is working on addressing social determinants of health, including TB. TB has often been described as a disease of poverty. Despite the enormous success of DOTS in treating and caring for those infected with TB, DOTS on its own is unlikely to achieve sustained, effective TB control globally. Combination approaches that simultaneously address the social and the biomedical dimensions of TB are urgently needed. In collaboration with a variety of partners, including WHO’s StopTB programme, UNDP is exploring such combination approaches, leveraging its experience in supporting action on the social determinants of HIV. Specifically, UNDP is exploring the ways in which emerging work in HIV-sensitive social protection might be translated to address the underlying socio-economic drivers of TB. UNDP is also working to promote and protect human rights for people living with HIV and AIDS and Tuberculosis. |
|
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Belarus Bolivia Bosnia and Herzegovina Cuba El Salvador Haiti Iran (Islamic Republic of) Iraq Kyrgyzstan Liberia Republic of Montenegro Sao Tome and Principe Sudan Syrian Arab Republic Tajikistan Togo Turkmenistan Zambia Zimbabwe |
Specializations | |
|
Advocacy, communication and social mobilization Provision of TB products Research and Development TB Healthcare Services Technical Assistance |
Specializations in Countries | |
| Advocacy, communication and social mobilization | Belarus |
| Advocacy, communication and social mobilization | Bolivia |
| Advocacy, communication and social mobilization | Bosnia and Herzegovina |
| Advocacy, communication and social mobilization | Cuba |
| Advocacy, communication and social mobilization | El Salvador |
| Advocacy, communication and social mobilization | Haiti |
| Advocacy, communication and social mobilization | Iran (Islamic Republic of) |
| Advocacy, communication and social mobilization | Iraq |
| Advocacy, communication and social mobilization | Kyrgyzstan |
| Advocacy, communication and social mobilization | Liberia |
| Advocacy, communication and social mobilization | Republic of Montenegro |
| Advocacy, communication and social mobilization | Sao Tome and Principe |
| Advocacy, communication and social mobilization | Sudan |
| Advocacy, communication and social mobilization | Syrian Arab Republic |
| Advocacy, communication and social mobilization | Tajikistan |
| Advocacy, communication and social mobilization | Togo |
| Advocacy, communication and social mobilization | Turkmenistan |
| Advocacy, communication and social mobilization | Zambia |
| Advocacy, communication and social mobilization | Zimbabwe |
| Provision of TB products | Belarus |
| Provision of TB products | Bolivia |
| Provision of TB products | Bosnia and Herzegovina |
| Provision of TB products | Cuba |
| Provision of TB products | El Salvador |
| Provision of TB products | Haiti |
| Provision of TB products | Iran (Islamic Republic of) |
| Provision of TB products | Iraq |
| Provision of TB products | Kyrgyzstan |
| Provision of TB products | Liberia |
| Provision of TB products | Republic of Montenegro |
| Provision of TB products | Sao Tome and Principe |
| Provision of TB products | Sudan |
| Provision of TB products | Syrian Arab Republic |
| Provision of TB products | Tajikistan |
| Provision of TB products | Togo |
| Provision of TB products | Turkmenistan |
| Provision of TB products | Zambia |
| Provision of TB products | Zimbabwe |
| Research and Development | Belarus |
| Research and Development | Bolivia |
| Research and Development | Bosnia and Herzegovina |
| Research and Development | Cuba |
| Research and Development | El Salvador |
| Research and Development | Haiti |
| Research and Development | Iran (Islamic Republic of) |
| Research and Development | Iraq |
| Research and Development | Kyrgyzstan |
| Research and Development | Liberia |
| Research and Development | Republic of Montenegro |
| Research and Development | Sao Tome and Principe |
| Research and Development | Sudan |
| Research and Development | Syrian Arab Republic |
| Research and Development | Tajikistan |
| Research and Development | Togo |
| Research and Development | Turkmenistan |
| Research and Development | Zambia |
| Research and Development | Zimbabwe |
| TB Healthcare Services | Belarus |
| TB Healthcare Services | Bolivia |
| TB Healthcare Services | Bosnia and Herzegovina |
| TB Healthcare Services | Cuba |
| TB Healthcare Services | El Salvador |
| TB Healthcare Services | Haiti |
| TB Healthcare Services | Iran (Islamic Republic of) |
| TB Healthcare Services | Iraq |
| TB Healthcare Services | Kyrgyzstan |
| TB Healthcare Services | Liberia |
| TB Healthcare Services | Republic of Montenegro |
| TB Healthcare Services | Sao Tome and Principe |
| TB Healthcare Services | Sudan |
| TB Healthcare Services | Syrian Arab Republic |
| TB Healthcare Services | Tajikistan |
| TB Healthcare Services | Togo |
| TB Healthcare Services | Turkmenistan |
| TB Healthcare Services | Zambia |
| TB Healthcare Services | Zimbabwe |
| Technical Assistance | Belarus |
| Technical Assistance | Bolivia |
| Technical Assistance | Bosnia and Herzegovina |
| Technical Assistance | Cuba |
| Technical Assistance | El Salvador |
| Technical Assistance | Haiti |
| Technical Assistance | Iran (Islamic Republic of) |
| Technical Assistance | Iraq |
| Technical Assistance | Kyrgyzstan |
| Technical Assistance | Liberia |
| Technical Assistance | Republic of Montenegro |
| Technical Assistance | Sao Tome and Principe |
| Technical Assistance | Sudan |
| Technical Assistance | Syrian Arab Republic |
| Technical Assistance | Tajikistan |
| Technical Assistance | Togo |
| Technical Assistance | Turkmenistan |
| Technical Assistance | Zambia |
| Technical Assistance | Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. Drug-Resistant TB: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. TB-HIV: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. Laboratory Strengthening: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. Fundamental Research: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. Operational Research: The Global Fund achieves its goals through a broad range of partnerships, of which its relationship with UNDP is a crucial component. Since 2003, the UNDP-Global Fund Partnership has focused on three interrelated objectives: (i) Supporting implementation, with UNDP serving as temporary Principal Recipient (PR) of Global Fund grants in countries facing exceptional development challenges and/or complex emergencies [in most other countries the Principal Recipients are national entities, i.e. Ministries of Health or national Non-Governmental Organizations (NGOs)]; (ii) Developing the capacity of national entities to take over the management of Global Fund programmes as soon as circumstances permit, or to improve their performance when they are already serving as Principal Recipients; and (iii) Strengthening policy and programme quality of Global Fund-related work, both at country and global levels, in line with UNDP’s role as a cosponsor of UNAIDS and UNDP’s core mandates in governance and capacity development. As of 1 December 2011, UNDP is supporting implementation of TB and/or TB/HIV grants by serving as temporary PR in 21 countries/territories, with 22 active grants (2-5 year duration). These countries include Belarus, Bosnia and Herzegovina, Kyrgyzstan, Republic of Montenegro, Tajikistan, Turkmenistan, Bolivia, Cuba, El Salvador, Haiti, Iraq, Sudan, South Sudan, Syrian Arab Republic, West Bank and Gaza, Iran, Liberia, Sao Tome and Principe, Togo, Zambia and Zimbabwe and support all key interventions in TB programming including DOTS Expansion and Enhancement, Drug Resistant TB, TB-HIV, Laboratory Strengthening, Fundamental Research and Operational Research. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | February 21, 2012 |
| Last updated: | December 3, 2012 |